Susan Swetter, M.D.

Publications

• Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY. Cancer. 2013; 119 (8): 1562-9
• Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines. Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dimaio D, Fleming MD, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, McMillian N, Ho M. J Natl Compr Canc Netw. 2013; 11 (4): 395-407
• A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Hiniker SM, Chen DS, Reddy S, Chang DT, Jones JC, Mollick JA, Swetter SM, Knox SJ. Transl Oncol. 2012; 5 (6): 404-7
• Attitudes toward indoor tanning among users of sunless tanning products. Mahoney A, Swetter SM, Biello KB, Resnick EA, Feuerstein I, Geller AC. Arch Dermatol. 2012; 148 (1): 124-6
• Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Cancer. 2012; 118 (15): 3725-34
• Examining the pathways linking lower socioeconomic status and advanced melanoma. Pollitt RA, Swetter SM, Johnson TM, Patil P, Geller AC. Cancer. 2012; 118 (16): 4004-13
• Gender disparities in patients with melanoma: breaking the glass ceiling. Sondak VK, Swetter SM, Berwick MA. J Clin Oncol. 2012; 30 (18): 2177-8
• Melanoma. Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. J Natl Compr Canc Netw. 2012; 10 (3): 366-400
• Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity. Curiel-Lewandrowski C, Swetter SM, Einspahr JG, Hsu CH, Nagle R, Sagerman P, Tangrea J, Parnes H, Alberts DS, Chow HH. Cancer. 2012; 118 (23): 5848-56
• Reporting and registering nonmelanoma skin cancers: a compelling public health need. Geller AC, Swetter SM. Br J Dermatol. 2012; 166 (5): 913-5
• Screening and prevention measures for melanoma: is there a survival advantage? Curiel-Lewandrowski C, Chen SC, Swetter SM. Curr Oncol Rep. 2012; 14 (5): 458-67
• Survival is not the only valuable end point in melanoma screening. Curiel-Lewandrowski C, Kim CC, Swetter SM, Chen SC, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Grichnik JM. J Invest Dermatol. 2012; 132 (5): 1332-7
• Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, Tsao H, Barbosa VH, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Smith Begolka W. J Am Acad Dermatol. 2011; 65 (5): 1032-47
• Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL. Nature. 2011; 470 (7334): 424
• Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Hausauer AK, Swetter SM, Cockburn MG, Clarke CA. Arch Dermatol. 2011; 147 (7): 783-9
• Reducing mortality in individuals at high risk for advanced melanoma through education and screening. Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. J Am Acad Dermatol. 2011; 65 (5 Suppl 1): S87-94
• The expanding melanoma burden in California hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location. Pollitt RA, Clarke CA, Swetter SM, Peng DH, Zadnick J, Cockburn M. Cancer. 2011; 117 (1): 152-61
• Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008. Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM. Pediatr Dermatol. 2010 May-Jun; 27 (3): 244-54
• Interaction of area-level socioeconomic status and UV radiation on melanoma occurrence in California. Clarke CA, Moy LM, Swetter SM, Zadnick J, Cockburn MG. Cancer Epidemiol Biomarkers Prev. 2010; 19 (11): 2727-33
• Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer. Rieger KE, Linos E, Egbert BM, Swetter SM. J Cutan Pathol. 2010; 37 (1): 59-67
• Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Spanogle JP, Clarke CA, Aroner S, Swetter SM. J Am Acad Dermatol. 2010; 62 (5): 757-67
• Efficacy of skin self-examination practices for early melanoma detection. Pollitt RA, Geller AC, Brooks DR, Johnson TM, Park ER, Swetter SM. Cancer Epidemiol Biomarkers Prev. 2009; 18 (11): 3018-23
• Factors associated with physician discovery of early melanoma in middle-aged and older men. Geller AC, Johnson TM, Miller DR, Brooks KR, Layton CJ, Swetter SM. Arch Dermatol. 2009; 145 (4): 409-14
• Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Geller AC, Elwood M, Swetter SM, Brooks DR, Aitken J, Youl PH, Demierre MF, Baade PD. Cancer. 2009; 115 (6): 1318-27
• Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Swetter SM, Layton CJ, Johnson TM, Brooks KR, Miller DR, Geller AC. Arch Dermatol. 2009; 145 (4): 488-90
• Impaired interferon signaling is a common immune defect in human cancer. Critchley-Thorne RJ, Simons DL, Yan N, Miyahira AK, Dirbas FM, Johnson DL, Swetter SM, Carlson RW, Fisher GA, Koong A, Holmes S, Lee PP. Proc Natl Acad Sci U S A. 2009; 106 (22): 9010-5
• Increasing burden of melanoma in the United States. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. J Invest Dermatol. 2009; 129 (7): 1666-74
• Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. Doeden K, Ma Z, Narasimhan B, Swetter SM, Detmar M, Dadras SS. J Cutan Pathol. 2009; 36 (7): 772-80
• Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Swetter SM, Johnson TM, Miller DR, Layton CJ, Brooks KR, Geller AC. Arch Dermatol. 2009; 145 (4): 397-404
• Melanoma. Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J, Wong MK. J Natl Compr Canc Netw. 2009; 7 (3): 250-75
• Selection criteria for genetic assessment of patients with familial melanoma. Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarrà G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H. J Am Acad Dermatol. 2009; 61 (4): 677.e1-14
• California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Pollitt RA, Clarke CA, Shema SJ, Swetter SM. Am J Prev Med. 2008; 35 (1): 7-13
• High-molecular-weight keratin stain as a complement to Melan A stain. Egbert BM, Rouse RV, Swetter SM. J Cutan Pathol. 2008; 35 (12): 1159
• Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? Cockburn M, Swetter SM, Peng D, Keegan TH, Deapen D, Clarke CA. J Am Acad Dermatol. 2008; 59 (6): 1081-5
• Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Cassarino DS, Cabral ES, Kartha RV, Swetter SM. Arch Dermatol. 2008; 144 (1): 49-56
• Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Swetter SM, Soon S, Harrington CR, Chen SC. Arch Dermatol. 2007; 143 (1): 30-6
• Evaluation of digital dermoscopy in a pigmented lesion clinic: clinician versus computer assessment of malignancy risk. Boldrick JC, Layton CJ, Nguyen J, Swetter SM. J Am Acad Dermatol. 2007; 56 (3): 417-21
• Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. J Am Acad Dermatol. 2007; 57 (4): 555-72; quiz 573-6
• Crafting a melanoma educational campaign to reach middle-aged and older men. Geller J, Swetter SM, Leyson J, Miller DR, Brooks K, Geller AC. J Cutan Med Surg. 2006 Nov-Dec; 10 (6): 259-68
• Sun care advertising in popular U.S. magazines. Lee ET, O'Riordan D, Swetter SM, Demierre MF, Brooks K, Geller AC. Am J Health Promot. 2006 May-Jun; 20 (5): 349-52
• A call for the development and implementation of a targeted national melanoma screening program. Geller AC, Miller DR, Swetter SM, Demierre MF, Gilchrest BA. Arch Dermatol. 2006; 142 (4): 504-7
• Facial resurfacing for nonmelanoma skin cancer prophylaxis. Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM. Arch Dermatol. 2006; 142 (8): 976-82
• Slow-growing nodule on the thigh. Stewart DB, Egbert BM, Rouse RV, Swetter SM. Arch Dermatol. 2006; 142 (7): 921-6
• Use of artificial tanning products among young adults. Brooks K, Brooks D, Dajani Z, Swetter SM, Powers E, Pagoto S, Geller AC. J Am Acad Dermatol. 2006; 54 (6): 1060-6
• Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction. Farrahi F, Egbert BM, Swetter SM. J Cutan Pathol. 2005; 32 (6): 405-12
• Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. J Invest Dermatol. 2005; 125 (4): 685-91
• Malignant Melanoma Swetter SM, eMedicine Journal [serial online]. Available at: http://www.emedicine.com/derm/topic257.htm. 2005
• Prevention and detection of melanoma in the primary care setting. Swetter SM, Geller AC. J Clin Outcomes Management. 2005: 12 523-34
• Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM. Arch Dermatol. 2005; 141 (8): 1016-22
• Sun protection factor content and warning statements for sunless tanning products: an examination of retail outlets and the Internet. Dajani Z, Swetter SM, Demierre MF, Geller AC. J Am Acad Dermatol. 2005; 53 (5): 919-20
• Vaccine therapy of melanoma: an update. Demierre M-F, Swetter SM, Sondak VK. Current Cancer Therapy Reviews. 2005: 1 115-25
• Diffuse verrucous, vascular nodules on the extremities and trunk. Nguyen J, Egbert BM, Swetter SM. Arch Dermatol. 2004; 140 (3): 353-8
• Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. Harrington CR, Egbert BM, Swetter SM. Dermatol Surg. 2004; 30 (5): 817-9
• Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis. Chang HY, Cooper ZA, Swetter SM, Marinkovich MP. Arch Dermatol. 2004; 140 (2): 242-4
• Melanoma in the older person. Swetter SM, Geller AC, Kirkwood JM. Oncology (Williston Park). 2004; 18 (9): 1187-96; discussion 1196-7
• Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. Fiorentino DF, Nguyen JC, Egbert BM, Swetter SM. J Am Acad Dermatol. 2004; 50 (3): 476-8
• Primary dermal melanoma: a distinct subtype of melanoma. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Arch Dermatol. 2004; 140 (1): 99-103
• Challenge. Epithelioid cell histiocytoma. Stewart DB, Egbert BM, Swetter SM. Am J Dermatopathol. 2003; 25 (5): 430-1, 445
• Current management of melanoma: benefits of surgical staging and adjuvant therapy. McMasters KM, Swetter SM. J Surg Oncol. 2003; 82 (3): 209-16
• Dermatological perspectives of malignant melanoma. Swetter SM, Surg Clin North Am. 2003; 83 (1): 77-95, vi
• Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. Swetter SM, Boldrick JC, Pierre P, Wong P, Egbert BM. J Cutan Pathol. 2003; 30 (2): 139-46
• Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California. Swetter SM, Waddell BL, Vazquez MD, Khosravi VS. Prev Med. 2003; 36 (2): 164-71
• Malignant melanoma. Kanzler MH, Swetter SM. J Am Acad Dermatol. 2003; 48 (5): 780-3
• Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea. Su LD, Kim YH, LeBoit PE, Swetter SM, Kohler S. J Cutan Pathol. 2002; 29 (3): 135-41
• Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Swetter SM, Carroll LA, Johnson DL, Segall GM. Ann Surg Oncol. 2002; 9 (7): 646-53
• Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Dubois RW, Swetter SM, Atkins M, McMasters K, Halbert R, Miller SJ, Shiell R, Kirkwood J. Arch Dermatol. 2001; 137 (9): 1217-24
• The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations Swetter SM, Ross MI. The Melanoma Letter. 2001; 19 (4): 1-4
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM. Nat Med. 1999; 5 (6): 677-85
• Hereditary ochronosis: hyperpigmented skin overlying cartilaginous structures. Garcia SF, Egbert B, Swetter SM. Cutis. 1999; 63 (6): 337-8
• Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. Swetter SM, Hill EL, Kern ER, Koelle DM, Posavad CM, Lawrence W, Safrin S. J Infect Dis. 1998; 177 (3): 543-50
• Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. Swetter SM, Yaghmai D, Egbert BM. J Cutan Pathol. 1998; 25 (8): 420-5
• Dopamine-associated symmetric peripheral gangrene. Park JY, Kanzler M, Swetter SM. Arch Dermatol. 1997; 133 (2): 247-9
• Cutaneous myiasis following travel to Belize. Swetter SM, Stewart MI, Smoller BR. Int J Dermatol. 1996; 35 (2): 118-20
• Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California. Wrone DA, Swetter SM, Egbert BM, Smoller BR, Khavari PA. J Am Acad Dermatol. 1996; 35 (6): 907-10
• Malignant melanoma from the dermatologic perspective. Swetter SM, Surg Clin North Am. 1996; 76 (6): 1287-98
• Surgical margins for malignant melanoma: another point of view. Kanzler MH, Swetter SM. J Am Acad Dermatol. 1996; 35 (6): 1014-5
• Scleredema revisited. A poststreptococcal complication. Cron RQ, Swetter SM. Clin Pediatr (Phila). 1994; 33 (10): 606-10
• Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. Swetter SM, Kindel SE, Smoller BR. J Am Acad Dermatol. 1993; 28 (2 Pt 2): 352-5